Picture of Lineage Cell Therapeutics logo

LCTX — Lineage Cell Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Brief: Lineage Initiates Clinical Study Of OPC1 For Spinal Cord Injury

Feb 11 (Reuters) - Lineage Cell Therapeutics  LCTX.A :
    * LINEAGE INITIATES CLINICAL STUDY OF OPC1 FOR SPINAL CORD
INJURY

Source text:  ID:nBw9Th3h0a 
Further company coverage:  LCTX.A 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Lineage Cell Therapeutics

See all news